Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Insulin Resistance 4Hyperglycemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Leukemia, Myeloid, Acute 1Leukemia 1Intracranial Aneurysm 1Hypoglycemia 1Hyperphagia 1Hyperinsulinism 1Congenital Abnormalities 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Insulin Glargine 4Insulin 3volagidemab 2Metformin 2Fulvestrant 2Alpelisib 2ziprasidone 1relacorilant 1pembrolizumab 1exemestane 1dapagliflozin 1Vildagliptin 1Tamoxifen 1Standard of Care 1Olanzapine 1Letrozole 1Insulin Lispro 1Insulin Aspart 1Injections 1DNA, Ribosomal 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Hyperglycemia × Insulin × Clear all
NCT03904199 2023-01-20

Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Completed
9 enrolled

Hyperglycemia

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed
61 enrolled

Hyperglycemia, Hyperphagia, Insulin Resistance

NCT00943709 2013-08-30

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Rutgers, The State University of New Jersey

Phase 3 Withdrawn
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Hyperglycemia, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡